Live Breaking News & Updates on Covid 19 treatment

Stay informed with the latest breaking news from Covid 19 treatment on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Covid 19 treatment and stay connected to the pulse of your community

#VisualAbstract: Simvastatin is non-superior to control in critically ill COVID-19 patients

Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Minute-medicine-inc , Covid-19 , Covid-19-treatment , Sars-cov-2 , Simvastatin , Studygraphics ,

COVID-19 Antivirals Can Trigger Viral Rebound

Though antivirals are critical for reducing severe COVID-19 symptoms, researchers suggested that the medication may not always be needed for milder cases.

Massachusetts , United-states , Boston , Mark-siedner , National-institutes-of-health , Variants-program , Massachusetts-consortium-on-pathogen-readiness , Hospital-department-of-medicine , Massachusetts-general-hospital , National-institutes , Massachusetts-consortium , Pathogen-readiness

Paxlovid Doesn't Reduce Most Post-COVID Conditions

With the exception of venous thromboembolism and pulmonary embolism events, the antiviral drug did not reduce the incidence of post-COVID-19 conditions in a study of nearly 10,000 US veterans.

United-states , American , George-ioannou , International-society-for-the-diabetic-foot , American-diabetes-association , Society-for-women , Korean-diabetes-association , Us-department-of-veterans-affairs , Brown-university , International-classification-of-diseases , Veterans-affairs , Internal-medicine

Long COVID Patients Seek Workers' Comp, Many Can't Collect

Among the workers struggling to receive benefits are essential workers -- hospital staff, medics, teachers, and others who often put themselves at higher risk for infection.

United-states , Virginia , Americans , Michele-lewane , Robert-moss , Bogdan-savych , Centers-for-disease , National-council-on-compensation-insurance , Resource-center , Workers-compensation-research-institute , Disease-control , National-council

Paxlovid Tied to Benefits in High-Risk Patients With COVID

The use of nirmatrelvir–ritonavir (Paxlovid) is associated with a lower risk for death or hospitalization in extremely vulnerable patients with COVID-19. Low-risk patients do not appear to benefit.

United-kingdom , Canada , Vancouver , British-columbia , Ohio , United-states , British , Colinr-dormuth , University-of-british-columbia , British-columbia-ministry-of-health , Medscape-coronavirus-resource-center

US Plans Shift of Merck COVID Treatment to Commercial Market

The government will stop distributing free doses of Merck's COVID-19 antiviral treatment molnupiravir by the middle of next month and expects it to be sold on the commercial market instead.

United-states , Ridgeback-biotherapeutics , Administration-for-strategic-preparedness , Drug-administration , Reuters , Merck-co , Pfizer , Human-services , Us-department-of-health , Strategic-preparedness , Michael-erman , Bill-berkrot

About 250,000 Courses of COVID Pill Administered Weekly

Pfizer's chief executive said on Tuesday that almost 250,000 courses of the drugmaker's oral antiviral COVID-19 treatment Paxlovid were being administered per week.

United-states , Bengaluru , Karnataka , India , Shweta-agarwal , Albert-bourla , Sriparna-roy , Us-department-of-health , Human-services , Pfizer , Reuters , Pfizer-inc

Pneumonia, Not Just Inflammation, May Cause Severe COVID

New research from Northwestern University and the University of Wisconsin, however, is pointing to bacterial pneumonia as the cause of many severe COVID deaths.

Northwestern-university , Illinois , United-states , New-york , Chicago , India , Italy , Italian , Jonas-schluter , University-of-wisconsin , Institute-for-systems-genetics , Medscape-coronavirus-resource-center

A Common Cold Might Set Some Up for Long COVID

The research in people with rheumatic diseases could have wider implications, including a blood-based biomarker to predict higher risk.

Upper-westside , New-york , United-states , Massachusetts , Boston , Zachary-wallace , Los-angeles , Oladunni-adeyiga , Fernando-carnavali , Nisha-viswanathan , Resource-center , Division-of-rheumatology

European Commission Approves First Tocilizumab Biosimilar

The biosimilar, commercially called Tyenne, is indicated to treat several autoimmune diseases as well as cytokine release syndrome and COVID-19.

Fresenius-kabi , Pierluigi-antonelli , Drug-administration , European-medicines-agency , European-commission , European-union , Chief-executive-officer-pierluigi-antonelli , Biologic-license-application , Rheumatoid-arthritis , A , Biologic-therapy , Biosimilars